companion diagnostics. - search results
If you're not happy with the results, please do another search
The deals with each partner will initially focus on the KRAS G12C mutation as found in non-small cell lung cancer (NSCLC), which accounts for approximately 13% of all NSCLC cases.
Prometheus Biosciences said its bioinformatics platform and advanced machine learning techniques will be used by Takeda Pharmaceutical as part of a global collaboration to...
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
The FDA has approved an expanded indication for Foundation Medicine’s FoundationOne®CDx, authorizing the test as a companion diagnostic for the AstraZeneca/Merck & Co. co-developed...
With I-O continuing as the hot area of cancer drug development, new classes of biomarkers have emerged for potential companion diagnostics
Dan Snyder, CEO of Molecular MD discusses the new era of companion diagnostics from new technologies to emerging biomarkers.
The approval opens the door for NGS-approved companion diagnostics and for companion diagnostics to move beyond one test for one drug
HTG's year-old collaboration with Merck KGaA now includes a complementary focus on translational programs as well as companion diagnostics.
Nucleai and Propath UK have announced a partnership to develop and validate an immunofluorescence assay focused on 30 immuno-oncology protein targets.
Memorial Sloan Kettering spin-out Paige will partner with Quest Diagnostics to develop precise AI-driven cancer assessment tools to speed up and improve diagnosis for patients with a range of solid tumors.